ISPC
iSpecimen·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 2
Bearish signal 2
Stock Price Surged Significantly
Significant Net Income Decline
EPS Beats Expectation
Revenue Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About ISPC
Ispecimen Inc.
An online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers
8 Cabot Road, Suite 1800, Woburn, Massachusetts 01801
--
ISpecimen Inc., was incorporated in 2009 under the laws of the State of Delaware. The company has developed and launched a proprietary online market platform that connects researchers with subjects, specimens and related data. ISpecimen is a technology-driven company founded to solve a key challenge: how to connect life science researchers who need human biofluids, tissues and living cells (" biological samples ") to the billions of biological samples provided by medical institutions around the world (but not easily available). The company's groundbreaking iSpecimen Marketplace platform aims to address this issue and transform the biological sample procurement process to accelerate medical discovery.
Company Financials
EPS
ISPC has released its 2025 Q3 earnings. EPS was reported at -0.48, versus the expected 0, missing expectations. The chart below visualizes how ISPC has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
ISPC has released its 2025 Q3 earnings report, with revenue of 106.59K, reflecting a YoY change of -96.00%, and net profit of -2.78M, showing a YoY change of -93.12%. The Sankey diagram below clearly presents ISPC's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
